[Molecular testing of prostate cancer: timing, methods and consequences]
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Molecular testing is increasingly important for understanding metastatic prostate cancer. This review covers current molecular diagnostics and their impact on targeted therapies, including hereditary predispositions.
Area Of Science
- Oncology
- Genetics
- Molecular Pathology
Background
- Metastatic prostate cancer is complex, with treatments typically based on tumor extent and patient factors, not molecular details.
- Molecular pathology is underutilized in current clinical decision-making for prostate cancer.
- Advances in next-generation sequencing (NGS) are improving molecular testing and understanding of prostate cancer development.
Conclusions
- Molecular pathology should be integrated into prostate cancer treatment decisions.
- Understanding molecular alterations is key to developing effective targeted therapies.
- Future prostate cancer management will likely involve more personalized, molecularly-guided approaches.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.